Comment
. 2006 Apr;32(4):604; author reply 610-2.
doi: 10.1007/s00134-006-0086-9.
Epub 2006 Mar 1.
When a single pivotal trial should not be enough-the case of drotrecogin-alfa (activated)
- PMID: 16508757
- DOI: 10.1007/s00134-006-0086-9
Item in Clipboard
Comment
When a single pivotal trial should not be enough-the case of drotrecogin-alfa (activated)
Intensive Care Med.
2006 Apr.
No abstract available
Comment on
-
Activated protein C: do more survive?Intensive Care Med. 2005 Dec;31(12):1624-6. doi: 10.1007/s00134-005-2829-4. Epub 2005 Oct 15. Intensive Care Med. 2005. PMID: 16228174 No abstract available.
Similar articles
-
Drotrecogin alfa: a second look. More clinical trials in severe sepsis: mostly negative results.Prescrire Int. 2007 Feb;16(87):7-9. Prescrire Int. 2007. PMID: 17323514
-
Drotrecogin alfa on trial.Lancet Infect Dis. 2009 Jan;9(1):2-3. doi: 10.1016/S1473-3099(08)70286-X. Lancet Infect Dis. 2009. PMID: 19095188 No abstract available.
-
Errors in the approval process and post-marketing evaluation of drotrecogin alfa (activated) for the treatment of severe sepsis.Lancet Infect Dis. 2009 Jan;9(1):67-72. doi: 10.1016/S1473-3099(08)70306-2. Lancet Infect Dis. 2009. PMID: 19095197
-
Use of drotrecogin alfa (activated) in older patients with severe sepsis.Pharmacotherapy. 2006 Apr;26(4):533-8. doi: 10.1592/phco.26.4.533. Pharmacotherapy. 2006. PMID: 16553513 Review.
-
Drotrecogin alfa (activated) in the treatment of severe sepsis.Expert Rev Anti Infect Ther. 2006 Aug;4(4):537-47. doi: 10.1586/14787210.4.4.537. Expert Rev Anti Infect Ther. 2006. PMID: 17009934 Review.
Cited by
-
The effects of sepsis on endothelium and clinical implications.Cardiovasc Res. 2021 Jan 1;117(1):60-73. doi: 10.1093/cvr/cvaa070. Cardiovasc Res. 2021. PMID: 32215570 Free PMC article.
-
Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? A bayesian analysis.PLoS One. 2008 May 28;3(5):e2291. doi: 10.1371/journal.pone.0002291. PLoS One. 2008. PMID: 18509455 Free PMC article.
-
[Endogenous anticoagulant therapy for sepsis. Success and failure].Internist (Berl). 2007 May;48(5):537-42, 544. doi: 10.1007/s00108-007-1840-y. Internist (Berl). 2007. PMID: 17390117 German.
-
Activated protein C: cost-effective or costly?Crit Care. 2007;11(5):164. doi: 10.1186/cc6090. Crit Care. 2007. PMID: 17875223 Free PMC article.
-
How many patients with severe sepsis are needed to confirm the efficacy of drotrecogin alfa activated? A Bayesian design.Intensive Care Med. 2008 Oct;34(10):1804-11. doi: 10.1007/s00134-008-1159-8. Epub 2008 May 27. Intensive Care Med. 2008. PMID: 18504550
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
